Compounds > staurosporine
Page last updated: 2024-08-23

staurosporine and isogranulatimide

staurosporine has been researched along with isogranulatimide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Anderson, E; Boardman, PE; Bryk, R; Chao, P; Cole, JL; Conn, GL; Duffy, NP; Griffin, JH; Nathan, C; Raimundo, BC; Wu, K1
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1
Andersen, RJ; Anderson, HJ; Berlinck, RG; Britton, R; Curman, D; Davies, P; Friend, SH; Haggarty, SJ; Kelly, MT; Lim, LY; Piers, E; Roberge, M; Stringer, CM; Vincent, I; Xu, L1

Other Studies

4 other study(ies) available for staurosporine and isogranulatimide

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Identification of new inhibitors of protein kinase R guided by statistical modeling.
    Bioorganic & medicinal chemistry letters, 2011, Jul-01, Volume: 21, Issue:13

    Topics: Animals; Computer Simulation; Dose-Response Relationship, Drug; eIF-2 Kinase; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Macrophages; Mice; Models, Statistical; Molecular Structure; Small Molecule Libraries

2011
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013
High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide.
    Cancer research, 1998, Dec-15, Volume: 58, Issue:24

    Topics: Adenocarcinoma; Animals; Breast Neoplasms; DNA Repair; G2 Phase; Genes, p53; Humans; Imidazoles; Indoles; Lung Neoplasms; Radiation-Sensitizing Agents; Staurosporine; Succinimides; Tumor Cells, Cultured

1998